-
Product Name
Tigatuzumab (Synonyms: ANTI-TRAIL-R2 MOAB; ANTI-DR5 MOAB)
- Documents
-
Description
Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (Tigatuzumab)
-
Tested applications
ELISA
-
Species reactivity
Human TNFRSF10B / TRAILR2 / CD262
-
Alternative names
ANTI-TRAIL-R2 MOAB antibody; ANTI-DR5 MOAB antibody
-
Isotype
IgG
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
1×PBS, pH 6.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (tigatuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
SEC-HPLC
The purity of Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (tigatuzumab) is more than 95%, determined by SEC-HPLC.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"